The Histiocytosis Association is a global nonprofit organization dedicated to addressing the unique needs of patients and families dealing with the effects of histiocytic disorders, a group of diseases that occur when there is an over-production of white blood cells known as histiocytes that can lead to organ damage and tumor formation in both children and adults. The only organization of its kind, HA works to encourage the patient and medical communities to improve and share knowledge of histiocytic disorders; provide critical emotional and educational support to patients and families; and identify and fund key research initiatives that lead to a world free of histiocytic disorders.
To that end, the foundation will award grants of up to $50,000 for research on the causes, mechanisms, and improved means of treatment for histiocytic disorders. While all areas of research relevant to the histiocytoses will be considered, priority will be given to studies related to mechanisms of disease pathogenesis; biology (maturation, migration, and immune function) of dendritic cells, macrophages, and/or lymphocytes in disease pathogenesis; derangements of cytokine production or function; CNS pathology; neuropsychiatric consequences; studies of rare forms (juvenile xanthogranuloma, Erdheim-Chester disease, Rosai-Dorfman disease); studies of histiocytic disorders in adults; and discovery of new disease markers.
To be eligible, all applicants must be a full-time faculty member at an academic institution.
See the Histiocytosis Association website for complete program guidelines, information about previously awarded grants, an FAQ, and proposal submission instructions.